Introducing REXULTI® (brexpiprazole): a new PBS-listed antipsychotic for schizophrenia
Por um escritor misterioso
Descrição
October 1st sees the PBS listing of REXULTI, a novel antipsychotic indicated for the treatment of adults with schizophrenia.
1mg REXULTI TABLET, Schizophrenia, Intas Pharmaceuticals
Rexulti Full Prescribing Information, Dosage & Side Effects
Brexpiprazole: A Newly Approved Atypical Antipsychotic Agent
Rexulti (Brexpiprazole) - PSYCH-MENTAL HEALTH HUB
ex9902004.jpg
ex9902003.jpg
Introducing REXULTI® (brexpiprazole): a new PBS-listed antipsychotic for schizophrenia
Brexpiprazole - Mechanism of Action and Clinical Application
PDF) Construction and evaluation of a phospholipid-based phase transition in situ gel system for brexpiprazole
FDA Approves New Schizophrenia, Depression Drug Brexpiprazole - Psychiatry Advisor
Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America
Full article: Pharmacokinetics and metabolism of brexpiprazole, a novel serotonin-dopamine activity modulator and its main metabolite in rat, monkey and human
ex9902006.jpg
Investigation Questions Drug's Approval for Agitation in AD
Rexulti.PDF
de
por adulto (o preço varia de acordo com o tamanho do grupo)
